Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Psilocybin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Psyence BioMed Ships GMP NPX-5 for Australia Phase IIb Trial
    Psyence BioMed Ships GMP NPX-5 for Australia Phase IIb Trial

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248502/0/en/Psyence-BioMed-Announces-Export-of-GMP-Manufactured-Natural-Psilocybin-NPX-5-to-Australia-for-Ongoing-Phase-IIb-Clinical-Trial.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Compass Pathways' Depression Drug Meets Main Goal in Late-Stage
    Compass Pathways' Depression Drug Meets Main Goal in Late-Stage

    23 Jun 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/compass-pathways-depression-drug-succeeds-late-stage-trial-2025-06-23/

    REUTERS
    23 Jun 2025
    Share Share
    Rose Hill Inks Export Deal for Psilocybin Supply to Brazil
    Rose Hill Inks Export Deal for Psilocybin Supply to Brazil

    13 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/13/3098998/0/en/Rose-Hill-Apothecary-Executes-First-Major-International-Export-Deal-Supplying-Research-Grade-Psilocybin-to-Brazil.html

    GLOBENEWSWIRE
    13 Jun 2025
    Share Share
    Compass Pathways Completes Dosing for Phase 3 COMP360 Trial
    Compass Pathways Completes Dosing for Phase 3 COMP360 Trial

    22 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250422821349/en/Compass-Pathways-Announces-Dosing-Complete-for-All-Participants-in-Part-A-of-Phase-3-COMP005-Trial-of-COMP360-Psilocybin-for-Treatment-Resistant-Depression

    BUSINESSWIRE
    22 Apr 2025
    Share Share
    Mikart Supports Cannabinoid & Psilocybin Drug Development
    Mikart Supports Cannabinoid & Psilocybin Drug Development

    18 Apr 2025

    // PRESS RELEASE

    https://www.mikart.com/navigating-emerging-therapeutics-how-mikart-supports-cannabinoid-and-psilocybin-drug-development/

    PRESS RELEASE
    18 Apr 2025
    Share Share
    Bionic Bloom: Cannadelic Miami 2025 Features Laura Hartman
    Bionic Bloom: Cannadelic Miami 2025 Features Laura Hartman

    09 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionic-bloom-presents-cannadelic-miami-2025-announces-featured-speake-1012524

    ACCESSWIRE
    09 Apr 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.